QTc Prolongation and Ventricular Trigemini with Asenapine: A Case Report
Document Type
Article
Publication Date
1-1-2017
Abstract
Asenapine is one of the newer atypical antipsychotics on the market. It is a sublingually administered drug that is indicated for the treatment of both schizophrenia and bipolar disorder, and is considered to be safe and well tolerated. Herein, we report a 71-year-old female with a history of bipolar disorder who had ventricular trigemini and experienced a large increase in her QTc interval after starting treatment with asenapine. These changes ceased following withdrawal of asenapine. In this case report, we discuss the importance of cardiac monitoring when switching antipsychotics, even to those that are considered to have low cardiac risk.
Keywords
Cognitive Behavioral Therapy, therapeutic effectiveness, efficacy, effectiveness, common factors, specific factors
Divisions
fac_med
Publication Title
Turkish Journal of Psychiatry
Volume
29
Issue
1
Publisher
Turkish Association of Nervous and Mental Health